Scaffolding to build a rational vaccine design strategy
- 11 October 2010
- journal article
- editorial
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 107 (42) , 17859-17860
Abstract
No abstract availableThis publication has 20 references indexed in Scilit:
- Elicitation of structure-specific antibodies by epitope scaffoldsProceedings of the National Academy of Sciences, 2010
- Computational Design of Epitope-Scaffolds Allows Induction of Antibodies Specific for a Poorly Immunogenic HIV Vaccine EpitopeStructure, 2010
- Ablation of the Complementarity-Determining Region H3 Apex of the Anti-HIV-1 Broadly Neutralizing Antibody 2F5 Abrogates Neutralizing Capacity without Affecting Core Epitope BindingJournal of Virology, 2010
- Confocal microscopy of giant vesicles supports the absence of HIV‐1 neutralizing 2F5 antibody reactivity to plasma membrane phospholipidsFEBS Letters, 2010
- Relationship between Antibody 2F5 Neutralization of HIV-1 and Hydrophobicity of Its Heavy Chain Third Complementarity-Determining RegionJournal of Virology, 2010
- Broadly Neutralizing Monoclonal Antibodies 2F5 and 4E10 Directed against the Human Immunodeficiency Virus Type 1 gp41 Membrane-Proximal External Region Protect against Mucosal Challenge by Simian-Human Immunodeficiency Virus SHIVBa-LJournal of Virology, 2010
- Vaccinology in the genome eraJournal of Clinical Investigation, 2009
- Broadly neutralizing anti-HIV-1 antibodies disrupt a hinge-related function of gp41 at the membrane interfaceProceedings of the National Academy of Sciences, 2009
- Structural Details of HIV-1 Recognition by the Broadly Neutralizing Monoclonal Antibody 2F5: Epitope Conformation, Antigen-Recognition Loop Mobility, and Anion-Binding SiteJournal of Molecular Biology, 2008
- Difficulties in eliciting broadly neutralizing anti-HIV antibodies are not explained by cardiolipin autoreactivityAIDS, 2007